Devastated with the sad news of the passing of Dimitri Karmpaliotis - I echo the comments made in @TCTMD, what a beautiful person and a great loss. A privilege and a pleasure working, enjoying opera, having long conversations during his visits to Madrid.

RT @SSinSF: Impressive #EuroPCR live case from @JEscaned & @NievesGonzalo1 on the use of CT to plan and manage cases - the dynamic Madrid d….

The extensive appendix of the @JACCjournals ultralow contrast PCI document addresses in detail specific CHIP scenarios and more (open access . Check also the Interactive Central Illustration, a nice feature allowing audio discussion of key points.

RT @JACCJournals: This #JACCINT analysis of 42,887 patients from the #SWEDEHEART registry shows comparable rates of #MACE (31.3% vs. 32.2%)….

PCI operators may find challenging switching to ultralow contrast PCI. The majority of them can be successfully addressed with technologies available in the cathlab as well as with a mindset change in the operators. See how to do it in (open access).

Beyond CKD, ULCPCI was developed and adopted by CTO operators because, not seldom, reaching contrast safety limits forced the procedure to be terminated. There are multiple CHIP scenarios in which ULCPCI may improve PCI safety and quality. Open access 🧵

Reducing dependence on vessel opacification is an important skill in CHIP PCI. In @JACCJournals we present a structured approach to ultralow contrast ULC PCI, highlighting its value in a wide range of complex scenarios. (open).@ziadalinyc @AsadKShabbir 🧵

RT @PCRonline: #EuroPCR 2025 selection meeting - did you know that on average 50% of the programme is based on submissions? . Register now….

A provocative question by Ajay Kirtane in the aftermath of the PREVENT trial, formulated at Tremblant Interventional Cardiology meeting 🇨🇦Any thoughts or comments? @PCRonline @shci_sec @sbrugaletta @GreggWStone @egutiMD

How does the presence of a CTO influence coronary physiology measurements in other vessels? What time-dependent physiological changes take place after successful CTO PCI? All this discussed in the article published today in @MyJSCAI Open access here:

RT @monaltiren: #PracticeGuidelnes.#InteventionalCardiology. NEW E S C C C S . G U I D E L I N E S:. @NievesGonzalo1🇪🇸 &. Erick Schampae….

RT @EuroInterventio: ❌NEW AHEAD OF PRINT❌."Coronary revascularisation deferral based on quantitative flow ratio or fractional flow reserve:….

Congratulations to Lin Wang for her PhD Cum Laude at @unicomplutense on the value of AngioIMR to predict MVO in STEMI 👏👏👏. A privilege serving as PhD Director. Now back to China to her new position in Beijing: looking forward to future collaborations! @IIS_IdISSC @CardioRed1

RT @CircIntv: Is CT Coronary Angiography prior to invasive coronary angiography in patients with prior bypass surgery of benefit? 3-year re….

A simpler approach to the diagnosis of INOCA/ANOCA: saline bolus thermodilution using IC adenosine. On top of simplicity, better assessment of IMR and CFR than with IV adenosine infusion. @HernanDMejiaR @InocaInternati1 @PCRonline @shci_sec.

I am impressed by the increasing - sometimes liberal- use of DCBs in de novo.coronary lesions. Looking forward to discussing to what point this is justified and what are the unmet needs of PCI.

RT @PCRonline: At 4pm Paris time 🕓 today attend this practical, accredited #PCRwebinar on drug-coated balloons as a first choice for patien….

RT @CardioOnco_JHE: Congratulations to Daniel Faria, @JEscaned and collagues for this publication! . Age‐related structural remodelling of….

RT @TCTMD_Yael: Using an AI-based QCA to help plan PCI may be as good as OCT guidance in achieving good MSA for noncomplex lesions, accordi….

RT @NielsRHolm: 1/x #QFR did not meet non-inferiority to FFR in the @FAVORIIITrial Europe presented by @B_Krogsgaard The 1-year primary EP….